Haleon plc/£HLN
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Haleon plc
Haleon plc is a consumer healthcare company that focuses on the development, manufacturing, and distribution of health products. The company operates in the healthcare industry, specifically targeting wellness and over-the-counter products. Haleon's portfolio includes well-known brands such as Sensodyne, Advil, and Centrum, which are aimed at providing solutions for oral health, pain relief, and dietary supplementation. Headquartered in the United Kingdom, the company maintains a global presence with a significant geographic footprint in numerous markets. Haleon's strategic positioning lies in its focus on scientifically backed consumer health products and a robust brand portfolio, which supports its competitive presence in the healthcare sector.
Ticker
£HLN
Sector
Primary listing
LSE
Employees
24,561
Headquarters
Website
Haleon plc Metrics
BasicAdvanced
£33B
20.28
£0.19
0.22
£0.07
1.81%
Price and volume
Market cap
£33B
Beta
0.22
52-week high
£4.16
52-week low
£3.64
Average daily volume
22M
Dividend rate
£0.07
Financial strength
Current ratio
0.922
Quick ratio
0.699
Long term debt to equity
47.361
Total debt to equity
52.621
Dividend payout ratio (TTM)
36.71%
Interest coverage (TTM)
7.32%
Profitability
EBITDA (TTM)
2,729
Gross margin (TTM)
64.69%
Net profit margin (TTM)
15.11%
Operating margin (TTM)
22.57%
Effective tax rate (TTM)
21.93%
Revenue per employee (TTM)
£450,000
Management effectiveness
Return on assets (TTM)
4.65%
Return on equity (TTM)
10.27%
Valuation
Price to earnings (TTM)
20.276
Price to revenue (TTM)
3.048
Price to book
2.03
Price to tangible book (TTM)
-3.63
Price to free cash flow (TTM)
15.136
Free cash flow yield (TTM)
6.61%
Free cash flow per share (TTM)
0.248
Dividend yield (TTM)
1.81%
Growth
Revenue change (TTM)
-1.81%
Earnings per share change (TTM)
17.83%
3-year revenue growth (CAGR)
0.53%
3-year earnings per share growth (CAGR)
17.25%
3-year dividend per share growth (CAGR)
43.55%
What the Analysts think about Haleon plc
Analyst ratings (Buy, Hold, Sell) for Haleon plc stock.
Haleon plc Financial Performance
Revenues and expenses
Haleon plc Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Haleon plc stock?
Haleon plc (HLN) has a market cap of £33B as of March 15, 2026.
What is the P/E ratio for Haleon plc stock?
The price to earnings (P/E) ratio for Haleon plc (HLN) stock is 20.28 as of March 15, 2026.
Does Haleon plc stock pay dividends?
Yes, the Haleon plc (HLN) stock pays dividends to shareholders. As of March 15, 2026, the dividend rate is £0.068 and the yield is 1.81%. Haleon plc has a payout ratio of 36.71% on a trailing twelve-month basis.
When is the next Haleon plc dividend payment date?
The next Haleon plc (HLN) dividend payment is scheduled for May 14, 2026.
What is the beta indicator for Haleon plc?
Haleon plc (HLN) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.